Paradigm Medical Communications, LLC

Paradigm Medical Communications, LLC Paradigm Medical Communications. n. Paradigm has been an ACCME-accredited provider of continuing medical education since 2007.

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. an exemplary, award-winning, medical education company that develops medical education activities using research-based needs assessments, which are innovative, well-designed, and well-executed, and that are continuously mon

itored to facilitate ongoing improvements. Paradigm has experience in developing and implementing CME programs in a wide variety of formats, including live events; print newsletters, monographs, and peer-reviewed journal supplements; electronic media (such as DVD); and web-based activities (including website design, development, and maintenance) as well as interdisciplinary web conferences, webinars, and podcasts. While Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, we also have several long-standing collaborative relationships with the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC)-accredited providers that enable our activities to offer continuing education credit to the broadest range of identified target audiences. All activities developed and implemented by Paradigm Medical Communications are in adherence with the Essentials and Standards of the ACCME as well as guidelines established by the AMA, OIG, PhRMA, and FDA. Paradigm Medical Communications, LLC is dedicated to providing effective education based on the needs of the medical community. By working with thought leaders in various therapeutic areas, Paradigm Medical Communications is committed to developing impactful and innovative medical education activities designed to improve patient care strategies and patient quality of life by modifying physician behavior through the use of evidence-based, compelling, and applicable information. Cme-Accredited Provider
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. We completed our 4-year reaccreditation in 2009. Content Areas

The content areas of activities sponsored by our CME program include, but are not limited to, the following therapeutic areas: oncology, dermatology, diabetes, aesthetic medicine, hyponatremia, invasive fungal disease, infectious diseases, respiratory disease, cardiovascular disease, men's health, rheumatology, and thrombosis

Target Audience

Categories of learners targeted for education include:

US-based physicians and other health care professionals who participate in local, regional, or national activities
International health professionals who attend national conferences and/or access internet CME activities
Types of Activities

The types of activities developed include:

Live activities (symposia, local and regional meetings, hospital-based/Grand Rounds, hands-on and simulation workshops, satellite broadcasts)
Enduring materials (DVDs, peer-reviewed journal supplements, print monographs/newsletters)
Internet CME (websites, interactive cases, webinars, podcasts)
Paradigm develops activities designed to meet the preferences of our learners. This means that multiple formats are considered and implemented based on the needs of each target audience and educational intervention. Expected Results

The results expected from all educational activities are to demonstrate a change in the competence and/or performance of health care professionals and to ultimately impact patient outcomes. Continued program evaluation and assessment assists us in ensuring that activity content is relevant to learner's current educational gaps.

“LAST CHANCE!” This program provides pediatric nurse practitioners and other clinicians who care for children with FA wi...
05/01/2026

“LAST CHANCE!” This program provides pediatric nurse practitioners and other clinicians who care for children with FA with a comprehensive review of the immunopathophysiology and diagnosis of immunoglobulin E-mediated FA and available therapies and data related to the use of biologic therapy in this disease. Experts will discuss the key aspects of FA management and contextualize the information in nurse practitioners’ role in important patient and caregiver conversations and care. Link in Bio or Scan QR code https://paradigmmed.org/1359

FEATURED FREE CME! View Now! Experts discuss strategies to overcome disparities in diabetic eye care. Scan QR code or vi...
04/30/2026

FEATURED FREE CME! View Now! Experts discuss strategies to overcome disparities in diabetic eye care. Scan QR code or visit link in our bio
Https://paradigmmed.org/1313

NEW COMPLIMENTARY CME! The clinical trials for alibercept 8 mg and faricimab enrolled patients with neovascular age-rela...
04/29/2026

NEW COMPLIMENTARY CME! The clinical trials for alibercept 8 mg and faricimab enrolled patients with neovascular age-related macular degeneration (nAMD) who were treatment-naïve. The treatment-experienced patient with nAMD is often the more common patient in clinical practice. Join this Points of View webinar with retina specialists who contextualize the current clinical outcomes of the pivotal trials and real-world data for these new agents. Key questions include: How are you deciding between first- and second-generation anti-VEGF agents for your patients with nAMD that is not responsive to the first anti-vascular endothelial growth factor (VEGF) agent they are given? How do the real-world studies inform your practice?Link in Bio or scan QR code Https://paradigmmed.org/1416-3SM

That’s a wrap! THANK YOU for attending our CME live symposium on the Advancements in Idiopathic Nephrotic Syndrome: Upda...
04/29/2026

That’s a wrap! THANK YOU for attending our CME live symposium on the Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management with our esteemed faculty Drs Keisha Gibson and William Smoyer!

NEW COMPLIMENTARY CME! This conversational CME program equips allergists with practical skills to apply shared decision-...
04/28/2026

NEW COMPLIMENTARY CME! This conversational CME program equips allergists with practical skills to apply shared decision-making in the management of food allergy (FA). Through brief lectures, case-based discussions, and communication demonstrations, participants learn to explore patient goals, assess risk tolerance, and guide conversations around diagnostic choices, avoidance strategies, and available treatments. The program emphasizes collaborative planning, clear risk communication, and addressing family concerns and health literacy barriers. By integrating shared decision-making, allergists can improve patient engagement, reduce decisional conflict, and support more personalized, confident FA care. Link in Bio or scan QR code Https://paradigmmed.org/1436SM

NEW COMPLIMENTARY CME! The landscape regarding diagnosis and treatment of HER2-low and -ultralow metastatic breast cance...
04/28/2026

NEW COMPLIMENTARY CME! The landscape regarding diagnosis and treatment of HER2-low and -ultralow metastatic breast cancer (mBC) is evolving. Our expert faculty will interpret the latest clinical trial data on antibody-drug conjugates (ADCs) and discuss how to apply updated guideline recommendations for optimal treatment selection and manage ADC-specific AEs. These evidence-based strategies tailored to HER2-low and HER2-ultralow expression profiles will enhance clinical decision-making and ultimately improve patient outcomes. Link in Bio or scan QR code
Https://parsdigmmed.org/1419-8SM

NEW COMPLIMENTARY CME! The new anti-vascular endothelial growth factor (VEGF) therapies, aflibercept 8 mg and faricimab,...
04/27/2026

NEW COMPLIMENTARY CME! The new anti-vascular endothelial growth factor (VEGF) therapies, aflibercept 8 mg and faricimab, add to the existing options for neovascular age-related macular degeneration therapy, including bevacizumab, ranibizumab, and aflibercept 2 mg. Using the new therapies requires a distillation of the essential features from pivotal clinical trials that can inform clinical practice combined with real-world use. Join this Point-Counterpoint Webinar with 2 retina experts who consider how the trials can inform clinical practice with a focus on fluid tolerance and treatment extension. With therapy intervals beyond 12 weeks, how have these new anti-VEGF therapies changed your practice? Link in Bio or scan QR code
Https://paradigmmed.org/1416-1SM

STARTING NOW!  Register to attend our Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and ...
04/25/2026

STARTING NOW! Register to attend our Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management. Complimentary CME offered. Join us tonight in person or via Zoom! Link in Bio or Scan QR code
Https://paradigmmed.org/1448LIVEMEETING

1-hour until SHOWTIME!  Join us in person or via Zoom! Register to attend our Advancements in Idiopathic Nephrotic Syndr...
04/25/2026

1-hour until SHOWTIME! Join us in person or via Zoom! Register to attend our Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management. Complimentary CME offered. Link in Bio or Scan QR code
Https://paradigmmed.org/1448LIVEMEETING

04/25/2026

Join us tonight in person or via Zoom! Register to attend our Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management. Complimentary CME offered. Link in Bio or Scan QR code Https://paradigmmed.org/1448LIVEMEETING

04/24/2026

Still time to register to attend our Advancements in Idiopathic Nephrotic Syndrome: Updates on Clinical Trial Data and Management. Complimentary CME offered. Join us in person or via Zoom —don’t miss out!
Link in Bio or Scan QR code Https://paradigmmed.org/1448LIVEMEETING

FEATURED FREE CME! Join our expert faculty for a discussion of how to personalize care of your patients with wet age-rel...
04/23/2026

FEATURED FREE CME! Join our expert faculty for a discussion of how to personalize care of your patients with wet age-related macular degeneration (AMD) using anti-vascular endothelial growth factor (VEGF) therapies. Link in bio or Scan the QR code
Https://paradigmmed.org/1345-3

Address

523 Route 303
Orangeburg, NY
10962

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Alerts

Be the first to know and let us send you an email when Paradigm Medical Communications, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Paradigm Medical Communications, LLC:

Share